Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
14.70
-0.90 (-5.77%)
Jan 21, 2025, 4:00 PM EST - Market closed
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $93.98 million as of January 21, 2025. Its market cap has increased by 211.63% in one year.
Market Cap
93.98M
Enterprise Value
77.62M
1-Year Change
211.63%
Ranking
Category
Stock Price
$14.70
Market Cap Chart
Since June 16, 2020, Forte Biosciences's market cap has decreased from $181.43M to $93.98M, a decrease of -48.20%. That is a compound annual growth rate of -13.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 99.74M | -31.31% |
| Dec 31, 2024 | 145.19M | 386.30% |
| Dec 29, 2023 | 29.86M | 42.17% |
| Dec 30, 2022 | 21.00M | -33.49% |
| Dec 31, 2021 | 31.57M | -93.24% |
| Dec 31, 2020 | 467.16M | 157.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |